← The Wire
GYRENasdaq
GYRE THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1124105
Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases
red 8-K · 90d
$575M
Market cap
$6.45
Last close
+2.5%
1D
+5.2%
5D
80K
Volume
Price · last 39 sessions-18.6%
May 4L $5.56 · H $8.04Jun 29
386
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 27, 2026DEF 14ADEF 14AApr 21, 2025DEF 14ADEF 14AApr 29, 2024DEF 14ADEF 14AApr 27, 2021DEF 14ADEF 14AMay 1, 2020DEF 14ADEF 14AMay 2, 2019DEF 14ADEF 14AMay 11, 2018DEF 14ADEF 14AMay 18, 2017DEF 14ADEFINITIVE PROXY STATEMENTJan 12, 2017DEF 14ADEF 14AApr 25, 2016DEF 14ADEFINITIVE PROXY STATEMENTNov 23, 2015DEF 14ANOTICE & PROXY STATEMENTApr 18, 2014
Similar companies
Comparable business profile · signals at a glance